Stockscreener 앱 받기
3.04
3.75%
0.11
시간 외 거래:
2.98
-0.06
-1.97%
전일 마감가:
$2.93
열려 있는:
$2.89
하루 거래량:
91,882
Relative Volume:
0.02
시가총액:
$13.16M
수익:
$2.07M
순이익/손실:
$-3.53M
주가수익비율:
-2.5844
EPS:
-1.1763
순현금흐름:
$-3.31M
1주 성능:
+1.33%
1개월 성능:
+101.99%
6개월 성능:
+49.02%
1년 성능:
-17.84%
1일 변동 폭
$2.8315
$3.09
1주일 범위
$2.8315
$3.11
52주 변동 폭
$1.0266
$8.48
Cyclerion Therapeutics Inc Stock (CYCN) Company Profile
명칭
Cyclerion Therapeutics Inc
전화
617-621-7722
주소
301 BINNEY STREET, CAMBRIDGE, MA
Compare CYCN vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CYCN
Cyclerion Therapeutics Inc
|
3.04 | 12.69M | 2.07M | -3.53M | -3.31M | -1.1763 |
VRTX
Vertex Pharmaceuticals Inc
|
430.14 | 108.36B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
731.77 | 78.05B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
775.03 | 48.74B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
302.11 | 41.16B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
298.16 | 33.17B | 5.36B | 287.73M | 924.18M | 2.5229 |
Cyclerion Therapeutics Inc Stock (CYCN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-10-20 | 개시 | Truist | Buy |
| 2021-09-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-06-03 | 개시 | Credit Suisse | Neutral |
Cyclerion Therapeutics Inc 주식(CYCN)의 최신 뉴스
CYCN stock is soaring 150% pre-market today — what is fueling the rally? - MSN
Cyclerion Merges with Korsana to Develop Alzheimer Antibody Therapy - HarianBasis.co
Cyclerion Therapeutics (CYCN) Merges With Korsana Biosciences to Advance Alzheimer’s Pipeline - Insider Monkey
5 Unstoppable Stocks That Could Double Your Money - Insider Monkey
Is Cyclerion (CYCN) stock outperforming similar companies (Drifts Higher) 2026-04-18Open Stock Signal Network - Cổng thông tin điện tử tỉnh Tây Ninh
Korsana deal gives investors control; Cyclerion to become Korsana Biosciences (CYCN → KRSA) - Stock Titan
Cyclerion Therapeutics stock soars 350% on Korsana merger, $380 million financing - MSN
Published on: 2026-04-13 23:21:17 - baoquankhu1.vn
Guidance Update: Is Cyclerion Therapeutics Incs growth already priced inEarnings Recap Summary & Fast Entry Momentum Alerts - baoquankhu1.vn
Are UNF, NSA, CYCN, ULYX Obtaining Fair Deals for their Shareholders? - Finviz
Are UNF, NSA, CYCN, ULYX Obtaining Fair Deals for their Sharehol - GuruFocus
Fed Watch: Is Cyclerion Therapeutics Incs growth already priced inQuarterly Earnings Summary & AI Optimized Trade Strategies - baoquankhu1.vn
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Cyclerion Therapeutics, Inc. (Nasdaq – CYCN), National Storage Affiliates (NYSENSA), Urgent.ly, Inc. (OTC MarketsULYX), UniFirst Corporation (NYSEU - ChartMill
12 Health Care Stocks Moving In Tuesday's After-Market Session - Sahm
Rate Hike: Is Cyclerion Therapeutics Incs growth already priced in2026 Historical Comparison & Expert Approved Momentum Ideas - baoquankhu1.vn
Halper Sadeh LLC is Investigating Whether SLNO, FORA, MKC, CYCN are Obtaining Fair Deals for their Shareholders - GlobeNewswire Inc.
Alzheimer’s company Korsana heads to NASDAQ via merger: Deals Report - BioCentury
CYCN Stock Price, Quote & Chart | CYCLERION THERAPEUTICS INC (NASDAQ:CYCN) - ChartMill
Penny stock CYCN surged more than 300% yesterday. Why, and should you chase the rally here? - MSN
CYCN PE Ratio & Valuation, Is CYCN Overvalued - Intellectia AI
CYCN Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
If You Invested $1,000 in Cyclerion Therapeutics Inc (CYCN) - Stock Titan
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Sahm
Globalstar, Exxon Mobil, Cyclerion Therapeutics, Eli Lilly And Intel: Why These 5 Stocks Are On Investors' Radars Today - Sahm
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Cyclerion Therapeutics, Inc. (NASDAQ: CYCN) - Sahm
Korsana Biosciences and Cyclerion Therapeutics Announce All-Stock Merger and $380 Million Financing - Global Legal Chronicle
Monteverde & Associates Investigates Cyclerion Therapeutics Merger - National Today
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
CYCN Plunges 17% After Merger Announcement: What’s Next for Cyclerion and Korsana? - Bitget
Cyclerion and Korsana Tie the Knot with a New Merger Strategy - StocksToTrade
Cyclerion Therapeutics Merger Sparks Investor Uncertainty - timothysykes.com
Penny Stock CYCN Surged More Than 300% Yesterday. Why, And Should You Chase the Rally Here? - Barchart.com
Korsana boosts Alzheimer’s work with reverse merger, $380M financing - BioWorld News
CYCN Stock Alert: Halper Sadeh LLC is Investigating Whether Cycle - The National Law Review
Cyclerion Therapeutics and Korsana Biosciences Announce $380M Merger to Advance Alzheimer’s Treatment KRSA-028 - Minichart
12 Health Care Stocks Moving In Wednesday's Intraday Session - Sahm
CYCN Stock Alert: Halper Sadeh LLC is Investigating Whether Cyclerion Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders - The Joplin Globe
Cyclerion Therapeutics, Inc. (CYCN) stock price, news, quote and history - Yahoo Finance UK
Cyclerion Therapeutics Merges with Korsana Biosciences in New Agreement - El-Balad.com
Korsana takes its brain shuttle tech public via reverse merger with Cyclerion - FirstWord Pharma
Shareholder Alert: Ademi LLP investigates whether Cyclerion Therapeutics Inc. is obtaining a Fair Price for Public Shareholders - PR Newswire
Korsana Biosciences and Cyclerion Therapeutics to Merge, Operate Under Korsana Name - Contract Pharma
Cyclerion Therapeutics to Merge with Korsana Biosciences - TipRanks
Cyclerion Therapeutics: $380 Million Financing To Merge With Korsana Biosciences And Advance Alzheimer’s Pipeline - Pulse 2.0
Cyclerion Therapeutics (NASDAQ: CYCN) to merge with Korsana, $380M PIPE backing - Stock Titan
Cyclerion to Merge With Korsana; $380 Million PIPE, CVRs and Lock-Ups Support Deal - TradingView
Korsana Biosciences to go public via Cyclerion (CYCN) reverse merger and $380M PIPE - Stock Titan
Korsana Taps Cyclerion For $380M Public Listing In Boston - Hoodline
Best Pharmaceutical Stocks To Follow NowApril 1st - MarketBeat
Promising Medical Stocks To ConsiderApril 1st - MarketBeat
Cyclerion provides public listing vehicle for Korsana in $380M deal - The Business Journals
Cyclerion Therapeutics Inc (CYCN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.29%
0.00%
자본화:
|
볼륨(24시간):